Back to results
US 6,887,883 B2Granted
Use of natural chrysanthone compounds having antiangiogenic activity
AssigneeSigma-Tau Industrie Farmaceutiche Riunite S.p.A.
InventorSergio Penco
Life of this patent
Estimating the term…
Abstract
A series of compounds of natural origin are described, as useful agents for the treatment of diseases characterised by abnormal angiogenesis. These compounds are: chrysanthone A having formula (I); chrysanthone B having formula (II); and chrysanthone C having formula (III).
Claims8
A method of combating angiogenic activity in a human comprising administering to said human a chrysanthone compound selected from the group consisting of:
Dependencies are inferred from the claim text.